Loading...
Please wait, while we are loading the content...
Similar Documents
HYVET ambulatory blood pressure substudy.
| Content Provider | Semantic Scholar |
|---|---|
| Author | Ben-Dov, Iddo Z. Bursztyn, Michael |
| Copyright Year | 2013 |
| Abstract | To the Editor: We read with interest the provocative Hypertension in Very Elderly Trial (HYVET) ambulatory blood pressure (ABP) article by Bulpitt et al.1 The main result is that white-coat hypertension (WCH) was present in half of HYVET patients at baseline. The authors hypothesized that the benefits of active treatment in HYVET may partially stem from treating individuals with WCH. To test this hypothesis, subgroup analysis of outcome in the active versus placebo arms according to baseline blood pressure status (sustained hypertension and WCH) is required. Such analysis cannot be made because of the small number of patients with available ABP. In its absence, the authors rely … |
| Starting Page | e42 |
| Ending Page | e42 |
| Page Count | 1 |
| File Format | PDF HTM / HTML |
| Alternate Webpage(s) | http://hyper.ahajournals.org/content/hypertensionaha/61/5/e42.full.pdf?download=true |
| PubMed reference number | 23460282v1 |
| Alternate Webpage(s) | https://doi.org/10.1161/HYPERTENSIONAHA.111.00884 |
| DOI | 10.1161/hypertensionaha.111.00884 |
| Journal | Hypertension |
| Volume Number | 61 |
| Issue Number | 5 |
| Language | English |
| Access Restriction | Open |
| Subject Keyword | Alveolar rhabdomyosarcoma Angiotensin-Converting Enzyme Inhibitors Blood Glucose Self-Monitoring Cerebrovascular accident Classification Diabetes Mellitus Diuretics Heart failure High Risk Acute Leukemia Hypertensive disease Indapamide Mercury Patients Perindopril Preterax SOCS7 gene Subgroup benefit |
| Content Type | Text |
| Resource Type | Article |
